Impairment in distinguishing spoken words from background noise may up Parkinson’s risk by 57% per 10 dB increase in the ...
Researchers at Shanghai Huashan Hospital have identified a novel therapeutic target that could lead to the world's first ...
MC Joseph, a 78-year-old prostate cancer survivor, experienced debilitating tremors due to Parkinson's disease. After ...
Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...
Magnetic Resonance-guided Focused Ultrasound tech has the potential to treat conditions like essential tremors & Parkinson’s, ...
It can be used treat essential tremor, Parkinson’s disease, epilepsy, and neuropathic pain through sound waves ...
The Vattikuti Foundation has donated a state-of-the-art Insightec MR-Guided HIFU system to AIIMS, along with five years of ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...
Those who discovered and named the condition said it had often been misdiagnosed as Parkinson's or Huntington's disease prior ...
Nicole LaBolle initially dismissed her shaking as something fairly common before facing a Parkinson's diagnosis at 28 ...
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD.
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results